About Lyell Immunopharma
We are entering a new era of medicine, where cancer is treated with cellular therapies: living, smart, targeted drugs. While enormous strides have been made, especially in hematologic cancers, the full promise of these therapies still lies ahead. Cell-based immunotherapies have yet to show substantial benefit in solid tumors, which represent the vast majority of cancers. Our goal is nothing less than to develop curative cell-based therapies for solid tumor cancers.
|
|
|
201-500 employees
View all Lyell Immunopharma employees
|
|
Biotechnology
|
|
201 Haskins Way, South San Francisco, CA 94080, US
|
|
2018
|
Lyell Immunopharma Alternatives
Frequently Asked Questions about Lyell Immunopharma
Evelyn Carranza is the CEO of Lyell Immunopharma.
Lyell Immunopharma Staff Directory
Search Lyell Immunopharma Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
